120 related articles for article (PubMed ID: 9469361)
21. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors.
Baranzelli MC; Kramar A; Bouffet E; Quintana E; Rubie H; Edan C; Patte C
J Clin Oncol; 1999 Apr; 17(4):1212. PubMed ID: 10561181
[TBL] [Abstract][Full Text] [Related]
22. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
23. Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM; Tabernero JM; Paz-Ares L; García-Llano JL; Mora J; Lianes P; Esteban E; Salazar R; López-López JJ; Cortés-Funes H
Cancer; 2000 Jan; 88(1):162-8. PubMed ID: 10618619
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.
Fosså SD; Oliver RT; Stenning SP; Horwich A; Wilkinson P; Read G; Mead GM; Roberts JT; Rustin G; Cullen MH; Kaye SB; Harland SJ; Cook P
Eur J Cancer; 1997 Aug; 33(9):1380-7. PubMed ID: 9337678
[TBL] [Abstract][Full Text] [Related]
25. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
[TBL] [Abstract][Full Text] [Related]
26. High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Beyer J; Kramar A; Mandanas R; Linkesch W; Greinix A; Droz JP; Pico JL; Diehl A; Bokemeyer C; Schmoll HJ; Nichols CR; Einhorn LH; Siegert W
J Clin Oncol; 1996 Oct; 14(10):2638-45. PubMed ID: 8874322
[TBL] [Abstract][Full Text] [Related]
27. Lactate dehydrogenase and its isoenzymes in testicular germ cell tumors: an overview.
von Eyben FE
Oncodev Biol Med; 1983; 4(6):395-414. PubMed ID: 6196755
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.
Koshida K; Kadono Y; Konaka H; Kitagawa Y; Imao T; Kobayashi T; Kunimi K; Uchibayashi T; Namiki M
Int J Urol; 1998 Jan; 5(1):74-9. PubMed ID: 9535605
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in metastatic germ cell tumors.
Schmoll HJ; Beyer J
Semin Oncol; 1998 Apr; 25(2):174-85. PubMed ID: 9562450
[TBL] [Abstract][Full Text] [Related]
30. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors.
Aoyama H; Shirato H; Ikeda J; Fujieda K; Miyasaka K; Sawamura Y
J Clin Oncol; 2002 Feb; 20(3):857-65. PubMed ID: 11821471
[TBL] [Abstract][Full Text] [Related]
31. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
32. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
[TBL] [Abstract][Full Text] [Related]
33. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
34. [Germ cell tumors in children and adolescents].
Göbel U; Calaminus G; Harms D
Praxis (Bern 1994); 1995 Sep; 84(39):1063-7. PubMed ID: 7481308
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
[TBL] [Abstract][Full Text] [Related]
36. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.
Steyerberg EW; Keizer HJ; Fosså SD; Sleijfer DT; Toner GC; Schraffordt Koops H; Mulders PF; Messemer JE; Ney K; Donohue JP
J Clin Oncol; 1995 May; 13(5):1177-87. PubMed ID: 7537801
[TBL] [Abstract][Full Text] [Related]
37. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
[TBL] [Abstract][Full Text] [Related]
38. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
[TBL] [Abstract][Full Text] [Related]
39. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
40. Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.
Timmerman JM; Northfelt DW; Small EJ
J Clin Oncol; 1995 Jun; 13(6):1391-7. PubMed ID: 7538557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
